Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • generic drug

    Tag: generic drug

    You Searched For "generic drug"
    Cipla to launch Cinacalcet Hydrochloride tablets, a generic version of Sensipar

    Cipla to launch Cinacalcet Hydrochloride tablets, a generic version of Sensipar

    Farhat Nasim7 March 2019 9:30 AM IST
    Cipla said, its cinacalcet hydrochloride tablets in the strengths of 30mg, 60mg and 90mg) is generic therapeutic equivalent version of Sensipar, a...
    Alembic Pharma JV Aleor gets USFDA nod for Clobetasol Propionate ointment

    Alembic Pharma JV Aleor gets USFDA nod for Clobetasol Propionate ointment

    Farhat Nasim6 March 2019 9:45 AM IST
    The company's JV, Aleor Dermaceuticals Ltd, has received approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug...
    Lupin, Natco receives USFDA nod for Imatinib Mesylate tablets

    Lupin, Natco receives USFDA nod for Imatinib Mesylate tablets

    Farhat Nasim6 March 2019 9:30 AM IST
    Imatinib Mesylate is a generic version of Novartis Pharmaceuticals Corporation's Gleevec tablets in the same strengths, Lupin said in a filing to BSE....
    Dr Reddys launches Tadalafil tablets for treating erectile dysfunction

    Dr Reddys launches Tadalafil tablets for treating erectile dysfunction

    Farhat Nasim13 Feb 2019 12:31 PM IST
    New Delhi: Hyderabad based drug major, Dr Reddy's has recently launched Tadalafil tablets in the US market. The drug launched is used to treat...
    Strides to exit investment in Arrow Pharma for over Rs 2000 crore

    Strides to exit investment in Arrow Pharma for over Rs 2000 crore

    Medical Dialogues Bureau30 Jan 2019 9:30 AM IST
    "Strides will receive AUD 300 million as upfront payment at the closure of the transaction, while the balance AUD 94 million to be deferred through a...
    Pharma giant Teva resists Israel PM on closure plan

    Pharma giant Teva resists Israel PM on closure plan

    Ruby Khatun Khatun21 Dec 2017 9:30 AM IST
    Jerusalem: Teva, the world's largest generic drug company, refused Tuesday to reconsider a decision to close its Jerusalem plant despite pressure from...
    Cadila gets USFDA nod for generic drug to treat Parkinson

    Cadila gets USFDA nod for generic drug to treat Parkinson

    Ruby Khatun Khatun15 Dec 2017 4:08 PM IST
    New Delhi: Cadila Healthcare said it has received approval from the US health regulator to market Pramipexole Dihydrochloride extended-release...
    US tribal patent deal could have big impact on generic drug market

    US tribal patent deal could have big impact on generic drug market

    Ruby Khatun Khatun14 Sept 2017 9:45 AM IST
    A groundbreaking deal between Allergan Plc and a Native American tribe to shield the company's patents in administrative proceedings could also be...
    Prev

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok